Want to see TSE:DHT.UN full AI Analyst Report?
DRI Healthcare (DHT.UN) Ratios
DRI Healthcare Ratios
TSE:DHT.UN's free cash flow for Q2 2026 was $33.60M. For the 2026 fiscal year, TSE:DHT.UN's free cash flow was decreased by $-6.50M and operating cash flow was $40.10M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.52 | 0.45 | 2.29 | 13.65 | 10.81 |
| Quick Ratio | 1.52 | 0.45 | 2.29 | 13.71 | 10.85 |
| Cash Ratio | 0.63 | 0.45 | 1.13 | 4.38 | 4.72 |
| Solvency Ratio | 0.10 | 0.21 | 0.66 | 0.27 | 1.10 |
| Operating Cash Flow Ratio | 1.17 | 1.90 | 1.38 | 9.25 | 7.02 |
| Short-Term Operating Cash Flow Coverage | 1.17 | 2.73 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -401.37M | $ -420.83M | $ -146.17M | $ -146.75M | $ 83.76M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.51 | 0.44 | 0.17 | 0.39 | 0.10 |
| Debt-to-Equity Ratio | 1.10 | 0.82 | 0.26 | 0.66 | 0.12 |
| Debt-to-Capital Ratio | 0.52 | 0.45 | 0.21 | 0.40 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.49 | 0.42 | 0.00 | 0.00 | 0.09 |
| Financial Leverage Ratio | 2.15 | 1.87 | 1.48 | 1.70 | 1.15 |
| Debt Service Coverage Ratio | 0.86 | -0.05 | 4.03 | 12.58 | 30.83 |
| Interest Coverage Ratio | 1.52 | 4.49 | 0.70 | 1.75 | 9.64 |
| Debt to Market Cap | 1.04 | 0.93 | 0.00 | 0.00 | 0.21 |
| Interest Debt Per Share | 12.87 | 8.30 | 3.87 | 6.52 | 1.33 |
| Net Debt to EBITDA | 4.77 | -80.10 | 0.77 | 2.71 | -0.27 |
| Profitability Margins | |||||
| Gross Profit Margin | -11.02% | 48.07% | -17.33% | 100.00% | 100.00% |
| EBIT Margin | -5.89% | 32.11% | 15.84% | 21.92% | 33.03% |
| EBITDA Margin | 47.27% | -3.56% | 91.55% | 96.12% | 90.08% |
| Operating Profit Margin | 31.41% | 114.73% | 15.84% | 14.52% | 29.40% |
| Pretax Profit Margin | -26.59% | -2.43% | 78.60% | 14.52% | 29.40% |
| Net Profit Margin | -26.31% | -2.43% | 77.91% | 14.52% | 29.40% |
| Continuous Operations Profit Margin | -26.31% | -2.43% | 77.91% | 14.52% | 29.40% |
| Net Income Per EBT | 98.97% | 100.00% | 99.12% | 100.00% | 100.00% |
| EBT Per EBIT | -84.65% | -2.12% | 496.20% | 100.00% | 100.00% |
| Return on Assets (ROA) | -5.46% | -0.34% | 10.98% | 1.83% | 4.94% |
| Return on Equity (ROE) | -11.73% | -0.64% | 16.30% | 3.11% | 5.69% |
| Return on Capital Employed (ROCE) | 7.01% | 17.60% | 2.39% | 1.86% | 5.09% |
| Return on Invested Capital (ROIC) | 6.45% | 17.72% | 2.37% | 1.86% | 5.11% |
| Return on Tangible Assets | -31.18% | -2.09% | 71.38% | 10.06% | 15.08% |
| Earnings Yield | -11.05% | -0.72% | 21.65% | 5.28% | 11.99% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.27 | 2.22 | 1.83 | 1.03 | 0.92 |
| Payables Turnover | 18.45 | 7.49 | 5.68 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.21 | 0.14 | 0.14 | 0.13 | 0.17 |
| Working Capital Turnover Ratio | -37.61 | 10.48 | 1.32 | 0.68 | 1.14 |
| Cash Conversion Cycle | 91.67 | 115.55 | 134.87 | 354.82 | 396.96 |
| Days of Sales Outstanding | 111.46 | 164.29 | 199.16 | 354.82 | 396.96 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 19.79 | 48.74 | 64.29 | 0.00 | 0.00 |
| Operating Cycle | 111.46 | 164.29 | 199.16 | 354.82 | 396.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.92 | 2.76 | 1.72 | 2.01 | 2.65 |
| Free Cash Flow Per Share | -0.28 | -2.30 | -7.06 | -5.11 | -6.71 |
| Dividend Paid and CapEx Coverage Ratio | 0.70 | 0.49 | 0.18 | 0.26 | 0.28 |
| Capital Expenditure Coverage Ratio | 0.87 | 0.54 | 0.20 | 0.28 | 0.28 |
| Operating Cash Flow Coverage Ratio | 0.16 | 0.36 | 0.53 | 0.32 | 2.09 |
| Operating Cash Flow to Sales Ratio | 0.40 | 1.12 | 0.65 | 0.97 | 1.25 |
| Free Cash Flow Yield | -2.46% | -27.90% | -74.29% | -89.78% | -129.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.45 | -138.34 | 4.62 | 18.92 | 8.34 |
| Price-to-Sales (P/S) Ratio | 2.38 | 3.36 | 3.60 | 2.75 | 2.45 |
| Price-to-Book (P/B) Ratio | 1.06 | 0.88 | 0.75 | 0.59 | 0.47 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -40.68 | -3.58 | -1.35 | -1.11 | -0.77 |
| Price-to-Operating Cash Flow Ratio | 5.95 | 2.99 | 5.53 | 2.83 | 1.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 1.34 | 0.01 | -0.37 | -0.00 |
| Enterprise Value Multiple | 9.80 | -174.32 | 4.70 | 5.57 | 2.45 |
| Enterprise Value | 904.42M | 860.98M | 505.20M | 427.77M | 162.02M |
| EV to EBITDA | 9.80 | -174.32 | 4.70 | 5.57 | 2.45 |
| EV to Sales | 4.63 | 6.21 | 4.30 | 5.36 | 2.21 |
| EV to Free Cash Flow | -79.18 | -6.63 | -1.61 | -2.17 | -0.70 |
| EV to Operating Cash Flow | 11.58 | 5.54 | 6.61 | 5.52 | 1.76 |
| Tangible Book Value Per Share | -8.34 | -5.26 | -3.27 | -3.78 | 2.46 |
| Shareholders’ Equity Per Share | 10.79 | 9.36 | 12.62 | 9.65 | 10.94 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.00 | 0.01 | -0.57 | -0.13 |
| Revenue Per Share | 4.81 | 2.46 | 2.64 | 2.07 | 2.12 |
| Net Income Per Share | -1.27 | -0.06 | 2.06 | 0.30 | 0.62 |
| Tax Burden | 0.99 | 1.00 | 0.99 | 1.00 | 1.00 |
| Interest Burden | 4.51 | -0.08 | 4.96 | 0.66 | 0.89 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.34 | 0.11 | 0.28 | 0.09 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| Income Quality | -1.52 | -48.53 | 0.83 | 6.68 | 4.26 |
Currency in USD
